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Abstract: Schistosomiasis, a neglected tropical disease of medical and veterinary importance, 25 
transmitted through specific freshwater snail intermediate hosts, is targeted for elimination in 26 
several endemic regions in sub-Saharan Africa. Multi-disciplinary methods are required for both 27 
human and environmental diagnostics to certify schistosomiasis elimination when eventually 28 
reached. Molecular xenomonitoring protocols, a DNA based detection method for screening disease 29 
vectors, have been developed and trialed for diseases transmitted by hematophagous insects, such 30 
as lymphatic filariasis and trypanosomiasis, yet none have been extensively trialed or proven 31 
reliable for schistosomiasis. Here, previously published universal and Schistosoma specific internal 32 
transcribed spacer (ITS) rDNA primers have been adapted into a triplex PCR primer assay that 33 
allows for simple, robust and rapid detection of Schistosoma haematobium and S. bovis in Bulinus 34 
snails. We show this two-step protocol can sensitively detect DNA of a single larval schistosome 35 
from experimentally infected snails and demonstrate its functionality for detecting S. haematobium 36 
infections in wild caught snails from Zanzibar. Such surveillance tools are a necessity for succeeding 37 
in and certifying the 2030 control and elimination goals set by the World Health Organization. 38 
Keywords: bovine; control; elimination; schistosomiasis; urogenital; surveillance; disease; parasite 39 
 40 
1. Introduction  41 
Schistosomiasis is a parasitic disease infecting an estimated 229 million people worldwide 42 
caused by parasitic worms of the genus Schistosoma, infection leading to severe morbidity and 43 
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mortality due to the associated complications of worm presence [1]. Schistosoma spp. in Africa are 44 
transmitted through specific freshwater snail intermediate hosts of the Bulinus and Biomphalaria 45 
genus [2]. Infections occur when humans or animals come into contact with freshwater containing 46 
infectious larval stages (cercariae) shed from the infected snails. Human schistosomiasis in Africa, 47 
where at least ~90% of those requiring treatment live [3], consists of two forms of the disease, 48 
urogenital and intestinal schistosomiasis, caused predominantly by Schistosoma haematobium and S. 49 
mansoni respectively [1]. Bovine, ovine and caprine schistosomiasis is also of significant veterinary 50 
and economic importance across sub-Saharan Africa [4,5] and is caused by infection of cattle, sheep 51 
and goats with species closely related to S. haematobium (termed S. haematobium group species), 52 
primarily S. bovis, S. curassoni and S. mattheei. Sympatric geographical distribution of schistosome 53 
species and overlapping intermediate snail host use of certain schistosome species and geographical 54 
strains, complicates disease transmission surveillance in (co)endemic zones [2,6,7]. 55 
The World Health Organization (WHO) aims for the elimination of human schistosomiasis as a 56 
public health problem, defined as >1% of the population with heavy intensity infections (50 57 
schistosome eggs per 10 ml of urine or 400 schistosome eggs per gram of faeces [8]), in all endemic 58 
countries by 2030 [9]. Despite great advances in schistosomiasis control mainly via preventative 59 
chemotherapy (praziquantel), the lack of protection against rapid re-infection together with the 60 
prolific asexual replication of schistosomes within their intermediate snail host presents substantial 61 
hurdles to achieving the targeted elimination of schistosomiasis. Very quickly snails can become 62 
infected by eggs emanating from untreated humans leading to rapid resurgence of transmission [10]. 63 
Therefore, adaptive treatment strategies that take into account the transmission dynamics of 64 
Schistosoma spp. with their snail hosts are required to control and eliminate the disease [11]. 65 
To better understand the local transmission dynamics of different Schistosoma species, allowing 66 
both human and bovine schistosomiasis to be monitored, a need exists for methodologies that detect 67 
schistosome infections in the intermediate host snails. These tools for assessing Schistosoma 68 
transmission could eventually be used during elimination programs to identify focal areas of 69 
persisting transmission or certify elimination and / or transmission interruption [12–14]. Defining 70 
ongoing transmission in snail populations through traditional methods of observing cercariae shed 71 
from snails is particularly challenging in an elimination setting such as the Zanzibar Archipelago 72 
where few snails (0.5 – 2.3%) are observed shedding cercariae [6,15]. Furthermore, snails with non-73 
patent (including pre-patent) infections are missed using these approaches. Where cercarial larval 74 
schistosomes are observed, these cannot be easily identified using morphological characteristics to 75 
species level (although relative position of sensory receptors is of some value [16,17]).  76 
Molecular xenomonitoring is a DNA-based method that has been developed to monitor the 77 
transmission of several vector borne diseases including trypanosomiasis [18,19], filariasis and malaria 78 
[20], helminthiases [21] and fascioliasis [22], including to some extent schistosomiasis [23–29]. 79 
Screening snails provides evidence on the extent of environmental contamination (i.e. schistosome 80 
miracidia penetrating snails) as well as environmental infection risk (i.e. schistosome sporocysts and 81 
cercariae developing inside the (pre-patent) snails, eventually emerging from the snail (patent)). Most 82 
of the available snail-schistosome xenomonitoring assays do not include internal controls [23,28,30], 83 
an important feature in any diagnostic tool that helps prevent false negative results [27]. Many assays 84 
just assume that a negative result means non-infection. 85 
In the current study, we adapted available universal [31] and Schistosoma specific [27] ITS rDNA 86 
primers to design a three primer multiplex assay and tested this as a simple, robust and rapid 87 
xenomonitoring PCR assay to enable the large-scale screening of Bulinus snails for Schistosoma 88 
infections (S. haematobium and S. bovis). We use a conventional PCR based approach focused on 89 
simplicity, ease of data interpretation, sensitivity and specificity with a primary aim to provide a 90 
xenomonitoring tool for monitoring S. haematobium transmission in endemic settings.  91 
2. Results 92 
2.1. In silico and in vitro Primer Evaluation 93 
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B. globosus and B. nasutus rDNA sequence data showed conserved primer binding sites for the 94 
universal primers ETTS2 and ETTS1 [31] at the 3’ end of the 18S and 5’ end of the 28S, flanking regions 95 
of the ITS, respectively. ETTS1 gave a 100% match and the ETTS2 primer showed just a single base 96 
pair mismatch. The resulting snail amplicon size predicted from these alignments was between 1232-97 
1263 bp and served as an internal snail control during PCR amplification. 98 
Alignments of the Schistosoma specific ITS primers (ITS2_Schisto_F and ITS2_Schisto_R [27]) 99 
showed 100% and 90% (2 mismatches) homology to S. haematobium and S. bovis respectively, with no 100 
cross reactivity to the Bulinus reference rDNA data. When paired with their opposing universal 101 
primers (ITS2_Schisto_F + ETTS1 or ITS2_Schisto_R + ETTS2) amplicon sizes of 538 and 835 bp were 102 
predicted respectively for Schistosoma. With the addition of the other universal primer to each 103 
combination (ETTS2 and ETTS1 respectively), the three-primer Multiplex ITS Xenomonitoring (MIX) 104 
reactions were predicted to be able to produce distinct amplicon profiles for non-infected snails (a 105 
single snail amplicon) and snails infected with Schistosoma spp. (three band profile). This was 106 
confirmed by in vitro testing of the primer combinations (Figure 1). 107 
 108 
Figure 1. Singleplex (A; ETTS2 + ETTS1) and multiplex (B; multiplex ETTS2 + ETTS1 + ITS2_Schisto_F, 109 
C; ETTS2 + ETTS1 + ITS2_Schisto_R) PCRs on laboratory bred Bulinus wrighti (B.w.) and Schistosoma 110 
haematobium (S.h.) gDNA separately (1; B.w., 2; S.h.) and combined (3; B.w. + S.h.). When B.w. and S.h. 111 
DNA is combined (A3, B3, C3), two amplicons are produced by the ETTS1 + ETTS2 primers, a larger 112 
snail amplicon (Sn) (~1200 bp) and a smaller Schistosoma amplicon (T) (~1000), with the additional 113 
Schistosoma specific primers producing either a 538 bp (B3; ITS2_Schisto_F) or 835 bp (C3; 114 
ITS2_Schisto_R) amplicon (S). A larger amplicon (A) (~1400-1600 bp) was also observed to be 115 
amplified in some reactions, this is thought to be a PCR artefact or additional primer targets in the 116 
Schistosoma gDNA. L1 = HyperLadder I (Bioline, London, UK). -ve = negative no template control. 117 
To maximise amplification efficiency/sensitivity and to provide good amplicon size 118 
differentiation, the multiplex PCR incorporating the internal ITS2_Schisto_F (Figure 1B) was selected 119 
for further development and testing. This primer combination was also selected as it targets the ITS2 120 
region for Schistosoma containing four species specific SNP’s enabling species identification (Table 1). 121 
The MIX assay proved robust at varying annealing temperatures (55ºC, 60ºC Figure 2A, 58ºC 122 
Figure 2B) and with 58ºC proving to be the most efficient, maximising specificity without decreasing 123 
sensitivity. Each of the three amplicons were extracted from the gel and sequenced, confirming the 124 
band identity and specificity of the primers to their target gDNA amplicon. These three bands are 125 
described as the snail (Sn) (1232 – 1263 bp), trematode (T) (~ 1000 bp) and Schistosoma (S) (538 bp) 126 
bands going forward. The secondary Schistosoma ITS xenomonitoring (SIX) PCR, solely targeting the 127 
Schistosoma amplicon proved robust, enabling single amplicon generation and sequencing (Figure 3). 128 
This provides a two-step PCR methodology with the MIX PCR for the initial high-throughput 129 
screening of the samples and the secondary SIX PCR to target specific samples for further infection 130 
clarification. 131 
 132 
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Table 1. Schistosoma species-specific SNP positions (including base position) in the ITS2 region. 133 
Schistosoma species 
ITS 2 Schistosome species specific SNP positions (bp) 
SNP1 (90) SNP2 (145) SNP3 (195) SNP4 (265) 
S. haematobium S. h (G) S. h (C) S. h (G) S. h (C) 
S. bovis S. b (A) S. b (T) S. b (A) S. b (T) 
 134 
 135 
Figure 2. Multiplex ITS xenomonitoring assay trial at 55ºC (A) and 60ºC (B). Includes gDNA of Bulinus 136 
wrighti of both BioSprint (Lane 1 and 5) and DNeasy extractions (Lane 2 and 6) and gDNA of 137 
Schistosoma haematobium (Lane 3 and 5) and S. bovis (Lane 4 and 6). Combinations of B. wrighti and S. 138 
haematobium (Lane 5) or S. bovis (Lane 6) gDNA shown. Sn = snail amplicon, T = trematode amplicon, 139 
S = Schistosoma amplicon and A = non-specific amplicon or artefact. L1 = HyperLadder I. L2 = 140 
HyperLadder IV (Bioline, London, UK). -ve = negative no template control. 141 
 142 
Figure 3. Gel showing the secondary singleplex ITS xenomonitoring (SIX) PCR for: 1) Schistosoma 143 
haematobium gDNA; 2) S. bovis gDNA; 3) S. haematobium + B. wrighti gDNA; 4) S. bovis + B. wrighti 144 
gDNA. – ve = non-template negative control. L1 = HyperLadder I (Bioline, London, UK). 145 
2.2. Analytical Sensitivity 146 
The assay proved highly sensitive with a LoD of 0.02 ng and 0.002 ng of gDNA for S. bovis and 147 
S. haematobium, respectively (Figure 4). Sensitivity appeared higher for S. haematobium (Figure 4), but 148 
in both cases the assay’s sensitivity is above that necessary to detect gDNA from a single miracidium, 149 
which ranges from 1.6-3.65 ng/µl [32]. At lower Schistosoma DNA concentrations the 1005 bp 150 
trematode band (T) lost sensitivity compared with the smaller Schistosoma specific band.  151 
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 152 
Figure 4. Sensitivity tests of ITS1-2-F PCR performed with serial dilutions of Schistosoma haematobium 153 
and S. bovis gDNA in the presence of Bulinus wrighti gDNA. L1 = HyperLadder I. L2 = HyperLadder 154 
IV (Bioline, London, UK). 155 
2.3. Experimental snail infections 156 
For the non-patent infections of B. truncatus with S. haematobium, preserved 24 h after exposure, 157 
61.1% (11 out of 18) B. truncatus were observed to be infected presenting the Schistosoma specific ITS2 158 
band (Figure 5). Infections were detected in snails exposed to 1, 2 and 7 miracidia. Two of the five 159 
(40%) B. truncatus exposed to one or two miracidia and left for 11 weeks, did not reach patency, but 160 
were also confirmed to be infected by the presence of S. haematobium amplicon (Figure 5: Lanes 20 161 
and 21). The secondary SIX PCR was performed on all 13 non-patent infected snails and the single 162 
amplicons were sequenced and confirmed as S. haematobium. Out of all the snails infected that 163 
survived until the end of the experiment (11 weeks), 15% (nine out of 62) reached patency of which 164 
two had been infected with two miracidia and seven with seven miracidia. One of these samples, 165 
infected with two miracidia, was analysed using the MIX PCR giving the expected triple banding 166 
pattern (snail, trematode and Schistosoma) (Figure 5: Lane 24). All three amplicons from this sample 167 
(Figure 5: Lane 24) were gel extracted and sequenced confirming their identification. Interestingly, in 168 
all the non-patent infections the large trematode amplicons (ETTS2-ETTS2) did not amplify (Figure 169 
5), due to the low level of Schistosoma DNA present in the snails that did not reach patency. 170 
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No. 
miracidi
a 
1 2 ~7 1 2 7 2 
+ve  + + +  + +  + +   + + + +    + +   + 
Figure 5. Experimental infections of Bulinus truncatus with Schistosoma haematobium (1-24) and field-172 
collected B. globosus infected with Euclinostomum sp. (Euc.) and field collected B. nasutus shedding 173 
Echinostoma sp. cercariae (Ech.). The S. haematobium DNA amplicon is present (+ve) in 13 of the 23 non-174 
patent snails (11 at 24 hours post exposure and two at 11 weeks post exposure) highlighted by the 175 
arrow. Lane 24 = B. truncatus sample that was shedding S. haematobium cercariae 11 weeks after 176 
exposure. Positive control (+ve) in a mix of B. wrighti and S. haematobium control gDNA. L1: 177 
HyperLadder I, L2: HyperLadder IV (Bioline, London, UK). 178 
2.4. Specificity testing 179 
The B. globosus with patent S. haematobium (n=2) and S. bovis (n=5) infections showed the expected 180 
triple banding pattern (snail, trematode and Schistosoma amplicons, results not shown) and following 181 
gel extraction and sequencing the data matched those from the cercariae collected from these samples 182 
(GenBank Accessions: MH014047 and MH014044, see [6]).  183 
When the MIX PCR was tested on snails confirmed to be infected with other commonly found 184 
trematode species (B. globosus infected with Euclinostomum sp. and the B. nasutus infected with 185 
Echinostoma sp. (Figure 5: Lanes Euc. and Ech.), no Schistosoma amplicon was observed. However, 186 
there was strong amplification of the trematode band together with the snail band. These trematode 187 
amplicons were gel extracted, sequenced and the infections confirmed as Euclinostomum sp. and 188 
Echinostoma sp., matching data from the cercariae originally collected from each snail. 189 
2.5. Testing on field samples  190 
From the 94 field collected B. globosus, 33 were shown to be infected with Schistosoma spp. with 191 
amplification of the Schistosoma specific band (Figure 6). Among them, eight also presented the 192 
trematode band. The internal snail control was amplified in all samples apart from one. The one that 193 
failed is predicted to be due to poor sample preservation, gDNA extraction or PCR error and so was 194 
disregarded (Figure 6). Of all the samples that gave the Schistosoma specific band, the secondary SIX 195 
PCR (ITS2_Schisto_F + ETTS2) was conducted and all amplicons were Sanger sequenced. Two failed 196 
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to amplify but the remaining 31 produced the Schistosoma amplicon that all sequenced as S. 197 
haematobium. One sample also gave the trematode band without the Schistosoma band indicating a 198 
non-Schistosoma trematode infection. 199 
 200 
Figure 6. Gel images for the multiplex ITS xenomonitoring (MIX) PCR amplicons for 94 non-patent 201 
Bulinus globosus collected from Wambaa, Pemba, United Republic of Tanzania. Text under each 202 
amplicon denotes the outcome of the Schistosoma sp. targeted sequencing where relevant (i.e. presence 203 
of 538 bp amplicon), which resulted in either S. haematobium (S.h.) or sequencing failure (F). Presence 204 
of a trematode band without the presence of the Schistosoma band indicates a non-Schistosoma 205 
trematode infection (Tr.). Other non-specific bands, in this case larger bands (NA) were also observed 206 
in these snail populations, which did not amplify with the secondary SIX PCR. x = sample failure with 207 
no control amplicon. Arrows highlight the presence of the ~1000 bp trematode band when present (n 208 
= 8). B. globosus with a patent S. haematobium infection (Cham10.1 see [6]) was run as a positive control 209 
(+ ve) and also represents the amplicon profile obtained for the seven patent B. globosus snail (five and 210 
two with S. bovis and S. haematobium infections, respectively (see section 2.4). -ve = the non-template 211 
negative control. L1 – HyperLadder IV (Bioline, London, UK). 212 
2.6. Schistosoma spp. cox1 RD-PCR 213 
Despite trying different annealing temperatures and gDNA template amounts used, the cox1 214 
RD-PCR developed by Webster et al. (2010) [33] tested on the patent S. haematobium and S. bovis 215 
infected B. globosus, only generated the species-specific amplicon for S. bovis infected snails. PCRs for 216 
the S. haematobium infected snails repeatedly failed to produce a clear amplicon. The cox1 amplicons 217 
produced for the S. bovis infected snails were sequenced and the data matched that obtained from the 218 
cercariae collected and analysed from the snails (see [6]). 219 
3. Discussion 220 
Pre-patent and non-patent snail screening methods for schistosomes, such as molecular 221 
xenomonitoring, offer a higher sensitivity over traditional snail shedding methods that can only 222 
detect patent infections (observation of schistosome cercariae). Molecular xenomonitoring better 223 
helps to assess the impact of schistosomiasis control interventions in local communities, particularly 224 
where local elimination is being achieved and certification of the absence of transmission is suspected 225 
at specific foci. However, the diversity of the Schistosoma species circulating in co-endemic areas 226 
means that species specific methodologies are needed to prevent false positive data related to non-227 
target species. 228 
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Here, we describe the development and application of a molecular xenomonitoring pipeline for 229 
the detection and differentiation of S. haematobium and S. bovis patent and non-patent infections in 230 
Bulinus freshwater snails, using three previously developed primers [27,31]. The MIX assay screens 231 
for Schistosoma and other trematode species, whilst also incorporating an internal control, in this case 232 
gastropod DNA, an important feature for any molecular diagnostic assay. The MIX PCR generates 233 
clearly identifiable amplicons, of different sizes, for each target (snail, trematode, Schistosoma) which 234 
are visible by simple agarose gel electrophoresis. However, the trematode target lacks sensitivity at 235 
low DNA concentrations, probably due to its large size and PCR biases for small amplicons at 236 
reduced gDNA concentrations. Interestingly, a PCR artefact (~1400-1600 bp) was also observed when 237 
using the MIX assay in the presence of Schistosoma DNA, suggesting that the primers may have a 238 
secondary binding site. However, this artefact is clearly identifiable from the main target amplicons 239 
and does not mislead interpretation of the results. 240 
3.1. Sensitivity of MIX PCR assay 241 
Our in silico and in vitro testing of the MIX assay showed that the presence of S. haematobium and 242 
S. bovis DNA can be routinely detected at low concentrations, and also was able to identify non-patent 243 
Schistosoma infections in snails where the level of DNA varies depending on the development of the 244 
infection. The LoD for Schistosoma DNA was 0.02 ng/µl, which is 80-fold lower than the minimum 245 
amount of gDNA usually observed from a single miracidia [32]. This was also demonstrated by the 246 
assay’s ability to detect pre-patent snail infections 24 h after exposure to a single miracidium. This 247 
provided sufficient sensitivity for the LoD of detection needed to detect any stage of snail infection, 248 
from initial miracidial penetration of a single miracidium to full patency, in natural settings. The fact 249 
that not all the snails tested from the experimental snail infections gave positive results is 250 
corroborative with observations that, even in experimental systems, many snails avoid penetration 251 
or destroy the miracidia rapidly upon invasion. The MIX and SIX methodology also proved robust 252 
when used to screen ‘wild caught’ snails from Pemba, with uninfected, pre-patent S. haematobium 253 
infected snails, and non-Schistosoma trematode infections clearly identified. 254 
3.2. Benefits of an updated molecular xenomonitoring protocol for schistosomiasis surveillance 255 
The molecular xenomonitoring protocol requires few consumables and no cold chain, and 256 
results can be interpreted using basic molecular laboratory equipment (thermocycler and gel 257 
electrophoresis) making the molecular assay accessible in lower resource settings, such as 258 
schistosomiasis endemic regions. The molecular xenomonitoring approach described here therefore 259 
provides a useful tool for monitoring schistosomiasis transmission, as has been outlined as a 260 
necessary method for leading toward the WHO 2030 goals for schistosomiasis control and 261 
elimination [9].  262 
Molecular xenomonitoring surveillance techniques are often associated with diseases 263 
transmitted by hematophagous insects, such as lymphatic filariasis in mosquito vectors [20,34–36] 264 
and trypanosomes in tsetse flies [18,19]. However, several assays have been developed for detecting 265 
trematode species in freshwater snails, including Fasciola spp. [22,37–44], other wildlife trematode 266 
species [45] and medically important schistosome species; S. japonicum [46,47], S. mansoni 267 
[24,27,28,48–54] and S. haematobium [23,26,27,30,52,54,55]. The first developed assay for the molecular 268 
detection of S. haematobium DNA in Bulinus employed the highly repetitive Dra1 target and this has 269 
been the marker of choice for studies investigating S. haematobium infections in snails due to its high 270 
sensitivity [55]. However, the specificity of the Dra1 and interpretation of results can be problematic 271 
due to the frequent false positive and negative results, lack of internal control, and difficulties in 272 
interpreting the amplicon patterns. Furthermore this marker does not allow for species identification. 273 
Kane et al. (2013) [54] employed the use of another repetitive marker, intergenic spacer (IGS), for the 274 
detection of snail infections and a post amplification restriction digest allowed for downstream 275 
species identification of S. haematobium and S. bovis. However the method lacks internal controls. In 276 
addition, many of these assays use quantitative-PCR (qPCR), rather than conventional PCR/gel 277 
electrophoresis. Although able to quantify levels of DNA within a sample, qPCR is more arduous to 278 
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carry out and lesser suited for use in endemic settings. However, recent technological advances in 279 
sample preparation and DNA extraction methods have demonstrated robust field setting 280 
methodologies to conduct qPCR analysis capable of detecting avian trematodes and host species in 281 
Canadian lakes [56–58], which could potentially be modified to suit the detection of human and 282 
bovine schistosomes in sub-Saharan Africa, although cost and throughput would need to be 283 
considered. 284 
A recent assay designed by Schols et al. (2019) [27] is a six primer multiplex PCR, that 285 
incorporates an internal snail control and offers a xenomonitoring tool for S. haematobium group 286 
species that are transmitted by Bulinus snail hosts. Our study simplifies the multiplex process, 287 
reducing the primer numbers and mitigating against PCR competition and biases that may occur 288 
with multiple primer combinations. It also allows for greater amplicon size differentiation (as 289 
amplicon sizes can be more easily distinguished based on size) making results more interpretable. 290 
The ITS rDNA is a favourable target within the repeat ribosomal operon of Bulinus and Schistosoma 291 
spp., easily detected within small quantities of DNA due to the high copy number of rRNA clusters 292 
within eukaryote genomes. The other key feature of the target relates to specificity. The ITS regions 293 
of Schistosoma and Bulinus spp. can be routinely amplified using conventional PCR thanks to its small 294 
size ~1000 bp) and highly conserved flanking regions (5’18S and 3’28S) enabling the use of universal 295 
primers (ETTS1+2) for multiple species [31]. However inter species heterogeneity, and to a lesser 296 
extent intra species heterogeneity (Pennance et al., unpublished observations), of the ITS regions 297 
allow for differentiation between species, such as those of the S. haematobium group [7,33]. The 298 
internal Schistosoma specific primer is situated in a conserved ITS region within the Schistosoma genus, 299 
with 100% conservation between several African species suggesting that it could be utilised for 300 
several Schistosoma-snail transmission systems. 301 
3.3. Limitations of molecular xenomonitoring approaches for schistosomiasis surveillance 302 
From our study, we identified two limiting factors for the practical use of the methodology. First, 303 
the laborious nature of testing each individual snail adds time and cost. Further sensitivity testing 304 
should be performed to support the development of pooling strategies. This would help to determine 305 
whether infections are still detected when the Schistosoma DNA is diluted in the presence of much 306 
higher concentrations of snail DNA, which may inhibit the reaction. Pooling strategies have been 307 
successful for arthropod xenomonitoring protocols [18] and would allow for higher throughput of 308 
samples required for screening large snail populations, such as those encountered for 309 
schistosomiasis.  310 
Second, a limitation does come with the need for the secondary screening (SIX PCR) of the 311 
Schistosoma amplicon, via sequencing, to confirm species. Despite best efforts, rapid species 312 
diagnostics, such as the rapid diagnostic cox1 RD-PCR developed by Webster et al. (2010) [33] to 313 
determine adult worm and larval stage species identity, was not robust when snail DNA was present, 314 
particularly for S. haematobium infections. The cox1 RD-PCR was suggested as a secondary screening 315 
method by Schols et al. (2019) [27] but it was only theoretically examined as part of that study. Clearly 316 
further ‘wet lab’ testing on infected snails is needed. In regions where Schistosoma hybridisation 317 
occurs, mitochondrial DNA analysis would be necessary, since both nuclear and mitochondrial DNA 318 
is required for hybrid identification [33]. Unfortunately, as with most diagnostics there is a balance 319 
between sensitivity and specificity, with sensitivity increasing and specificity decreasing, usually due 320 
to the nature of the biomedical targets. Here, rapid screening with high sensitivity was a priority due 321 
to the extremely low levels of infections in our study sites, with secondary species-specific screening 322 
only required on a small subset of samples that were identified as infected. Moreover, Zanzibar was 323 
previously thought to be a zone of S. haematobium transmission only, although with the recent 324 
occurrence of S. bovis transmission being observed [6], the additional species specific screening is 325 
warranted. However, the need for the secondary screening step for Schistosoma species identification 326 
does need further exploration such as trialing more direct methods that mitigate DNA sequencing, 327 
for example, amplicon enzyme restriction digestion demonstrated in Kane et al. (2013) [54]. However, 328 
it is also important to gather detailed information, as is obtained through DNA sequencing and 329 
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analysis, on species complexities and diversity within target endemic zones to optimise focal 330 
surveillance strategies [6,7]. It is likely that xenomonitoring methods may need to be adapted to 331 
specific endemic zones due to geographical genetic difference of the target organisms and potential 332 
unidentified species. 333 
4. Materials and Methods  334 
4.1. Primer selection and in silico evaluation 335 
The universal primer pair, ETTS2 and ETTS1 (Table 2 and Figure 7), was selected for the 336 
development of the internal control for the assay. They anneal to conserved flanking regions either 337 
side of the ITS(1+2) rDNA region of Schistosoma spp., amplifying the full ITS rDNA regions resulting 338 
in an amplicon of ~ 1005 bp [6,7,31,33]. These primers have also been demonstrated to amplify the 339 
full ITS rDNA region of other organisms including intermediate gastropod hosts. Primer cross 340 
reactivity with the target Bulinus snail hosts was further confirmed through alignments of the ETTS2 341 
and ETTS1 primers with B. globosus and B. nasutus rDNA regions, available from ongoing projects 342 
(Briscoe et al. unpublished data, Pennance et al. unpublished data).  343 
To develop the Schistosoma specific target, two Schistosoma specific primers (ITS2_Schisto_F and 344 
ITS2_Schisto_R) published by Schols et al. (2019) [27] were selected targeting the internal ITS1 and 345 
ITS2 rDNA regions of Schistosoma (Figure 7). These were further tested in silico for specificity by 346 
stringently aligning them with rDNA sequence data (Briscoe et al., unpublished data; Pennance et al., 347 
unpublished data) of a single B. globosus and B. nasutus from both Unguja and Pemba island 348 
(Zanzibar, United Republic of Tanzania) and those previously published for Schistosoma spp. [59,60]. 349 
All alignments were performed using Sequencher v5.4.6 (Gene Codes Corporation, Michigan, 350 
USA) and primer positions were used to predict the specific amplicon sizes that would result 351 
following amplification of snail and schistosome DNA using the different primer combinations of 352 
ETTS1, ETTS2, ITS2_Schisto_F and ITS2_Schisto_R. 353 
Table 2. Details of the primers selected for the development of the xenomonitoring assay. Universal 354 
(U) and specific (S) denotes whether the primers universally targets both Schistosoma and snail or just 355 
specifically target Schistosoma DNA. 356 
Primer (direction) Primer Sequence (5’-3’) Primer position State Reference 
ETTS1 (Reverse) TGCTTAAGTTCAGCGGG 
28S 5’ end (ITS2 3’ flanking 
region)  
U 
Kane et al. 
(1994) 
[31] 
ETTS2 (Forward) TAACAAGGTTTCCGTAGGTGA 
18S 3’ region (ITS1 5’ 
flanking region) 
U 
Kane et al. 
(1994) 
[31] 
ITS2_Schisto_F 
(Forward) 
GGAAACCAATGTATGGGATTATTG 
ITS1 3’ end (5.8S 5’ flanking 
region) 
S 
Schols et al. 
(2019) 
[27] 
ITS2_Schisto_R 
(Reverse) 
ATTAAGCCACGACTCGAGCA  ITS2 (middle) S 
Schols et al. 
(2019) 
[27] 
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 357 
Figure 7. Primer annealing positions flanking and internal to the ITS1+2 rDNA targets. Primer 358 
positions are mapped to Schistosoma haematobium and S. bovis ITS1+2 reference data [59], and to a 359 
Bulinus globosus and B. nasutus DNA reference (Pennance et al., unpublished data). For Schistosoma 360 
DNA the primer combinations produce two fragments; 1) ETTS2-ETTS1 (1005 bp) and either 2) 361 
ITS2_Schisto_F-ETTS1 (538 bp) or 3) ITS2_Schisto_R-ETTS2 (835 bp). For Bulinus DNA the primer 362 
combinations produce one fragment ranging in size between 1232-1263 due to inter species variation. 363 
For Schistosoma species identification four SNPs are present at bp positions 90, 145, 195, and 265 in the 364 
ITS2 rDNA region, allowing differentiation of S. haematobium and S. bovis following ITS2 sequencing. 365 
4.2. Bulinus and Schistosoma genomic DNA extractions 366 
Whole soft tissue from Bulinus samples (as detailed below) available through the Schistosomiasis 367 
Collection at the Natural History Museum (SCAN) [61] and other ongoing projects, including 368 
laboratory and field samples, infected / non-infected and patent / non-patent, were used for the assay 369 
development and validation. Genomic DNA (gDNA) from all Bulinus samples were extracted using 370 
a modified tissue lysis protocol [6]. Two kits were then used to extract total gDNA from the lysed 371 
snail tissue, the BioSprint 96 DNA Blood Kit (Qiagen, Manchester, UK) for high-throughput multiple 372 
sample processing, and the DNeasy Blood & Tissue Kit (Qiagen, Manchester, UK) for single sample 373 
processing. Protocols were carried out according to the manufacture instructions. 374 
Positive control Schistosoma gDNA was obtained from adult worms, S. haematobium (single 375 
female worm from Zanzibar) and S. bovis (single male worm from Senegal), available from SCAN. 376 
DNA was extracted following the DNeasy Blood & Tissue Kit protocol according to manufacturer’s 377 
instructions (Qiagen, Manchester, UK) [60]. 378 
4.3. PCR conditions, amplicon visualisation and sequencing 379 
All PCR amplifications were performed in 25 µl PCR reactions using illustraTM PuReTaq Ready-380 
To-GoTM PCR Beads (GE Healthcare, UK) with 1 µl of each primer, in their different combinations as 381 
stated in each section, at a concentration of 10 µM. gDNA templates (Schistosoma and/or Bulinus sp.) 382 
were added at different volumes and concentrations as detailed below. The PCR cycling conditions 383 
for all multiplex and singleplex reactions were as follows: initial denaturation 5 minutes at 95ºC 384 
followed by 40 cycles of 30 seconds at 95ºC, 30 seconds at 58ºC (unless stated otherwise), 90 seconds 385 
at 72ºC and a final extension of 10 minutes at 72ºC. Visualisation of all PCR products were performed 386 
by running 7.5 µl of each PCR product, mixed with 2 µl of Bioline 5x DNA Loading Buffer Blue 387 
(London, UK) and GelRed for visualisation under UV light, on a 2% agarose gel for 90 minutes at 90 388 
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V. HyperLadder I and HyperLadder IV were run alongside the PCR amplicons to assess fragment 389 
sizes. Gels were visualised using a GBOX-Chemi-XRQ gel documentation system (Syngene, 390 
Cambridge, UK). 391 
To validate amplification specificity, selected PCR amplicons from multiplex PCRs, where 392 
multiple amplicons are present, were cut from agarose gels and sequenced following purification 393 
using the QiaQuick Gel purification kit (Qiagen, Manchester, UK) following manufacturer’s 394 
instructions. For singleplex reactions, resulting in a single amplicon, PCR products were purified 395 
using the QiaQuick PCR purification kit (Qiagen, Manchester, UK) following manufacturer’s 396 
instructions. Amplicons were Sanger sequenced in both directions using dilutions of the PCR 397 
primers. Sequence data was manually edited using Sequencher v5.4.6 (Gene Codes Corporation, 398 
Michingan, USA) and amplicon identification was confirmed by comparison to Schistosoma reference 399 
data [59] and by BLAST analysis (BLAST: Basic Local Alignment Search Tool, NCBI). 400 
4.4. In vitro primer testing and assay validation 401 
All gDNA extractions from laboratory-bred Bulinus wrighti (not exposed to any trematodes and 402 
therefore negative for infection) and from the S. haematobium and S. bovis adult worms were 403 
quantified using a Qubit® Fluorometer using the dsDNA Broad Range (BR) Assay Kit (Molecular 404 
Probes, Life Technologies). The gDNA extracts from the single adult S. haematobium and S. bovis 405 
worms were normalised, using nuclease free water, to 2 ng/µl (+/- 0.05 ng/µl). The gDNA extract of a 406 
B. wrighti snail control was recorded and kept at 31.3 ng/µl. Template gDNA (1 µl) was used in each 407 
PCR separately or combined and used to test the different primer combinations (shown in Figure 1). 408 
The primers were tested as singleplex PCRs for the internal control (ETTS2 + ETTS1) targeting both 409 
snail and Schistosoma gDNA and then as multiplex PCR’s incorporating each of the internal 410 
Schistosoma specific primers (ETTS2 + ETTS1 + ITS2_Schisto_F or ITS2_Schisto_R). All test PCRs were 411 
initially performed at an annealing temperature of 55ºC. 412 
The multiplex primer combination ETTS2 + ITS2_Schisto_F + ETTS1 was selected and taken 413 
forward for further development and validation. This is referred to as the Multiplex ITS 414 
Xenomonitoring (MIX) PCR. The MIX PCR was further tested at annealing temperatures of 58º and 415 
60ºC to enhance assay specificity, with 58ºC taken forward for further experiments. Additionally, a 416 
secondary Schistosoma ITS xenomonitoring (SIX) PCR, incorporating just the Schistosoma specific 417 
primer (ITS2_Schisto_F) and its universal reverse primer (ETTS1), was validated targeting just the 418 
538 bp Schistosoma DNA amplicon. The SIX PCR was developed to obtain more targeted schistosome 419 
species data amplicon sequence analysis, of positive samples, following initial high-throughput 420 
screening of snail populations with the multiplex PCR, which incorporates the internal snail control. 421 
4.5. Sensitivity testing 422 
Analytical sensitivity and limit-of-detection (LoD) of the MIX PCRs ability to detect low levels 423 
of Schistosoma DNA, was performed using serial dilutions of S. haematobium and S. bovis gDNA. The 424 
S. haematobium and S. bovis gDNA, normalised to 2 ng/µl (+/- 0.05 ng/µl), was diluted using nuclease 425 
free water by one in ten (0.2 ng/µl), one in one hundred (0.02 ng/µl) and one in one thousand (0.002 426 
ng/µl). 1 µl of each Schistosoma gDNA dilution was used in each multiplex PCR together with 1 µl of 427 
the B. wrighti gDNA (31.3 ng/µl). 428 
Sensitivity was also tested using controlled laboratory snail infections. Infections were 429 
performed by the Schistosomiasis Resource Centre (SRC) (Biomedical Research Institute, Maryland, 430 
USA [62]) using their B. truncatus / S. haematobium (Egyptian strain) model lifecycle system. Juvenile 431 
B. truncatus (2-3 mm, n=133) were divided into three groups, with individual snails in each group 432 
being exposed to either 1, 2 or several (~7) S. haematobium miracidia respectively (Table 3). Miracidia, 433 
hatched in freshwater from eggs collected from S. haematobium infected male LVG Syrian golden 434 
hamsters (see Ethical Statement), were added to individual B. truncatus snails which had been placed 435 
in fresh snail water, in individual wells of a 24 well ELISA plates. A fine tipped Pasteur pipet was 436 
used under a dissection microscope to capture and deliver either an individual miracidium or several 437 
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(~7) miracidia at a time, following the standard operating procedures (SOPs) conducted at SRC (see: 438 
https://www.afbr-bri.org/schistosomiasis/standard-operating-procedures/). 439 
The snails were kept in their individual wells until no miracidia were observed swimming under 440 
a binocular microscope, assumed to have penetrated the snail (~2 h). Following 24 h after initial 441 
exposure to the miracidia, half of each infection group were preserved in 100% ethanol for molecular 442 
analysis. The remaining exposed B. truncatus were maintained in their separate infection groups for 443 
11 weeks to allow the infections to mature and since this was the first opportunity to conduct 444 
sampling of infected snails. Snails were maintained according to the SRC’s SOP’s (see above). Snails 445 
that died were recorded and promptly removed from the group. At 11 weeks post exposure the 446 
remaining snails were individually induced to shed cercariae by exposure to fresh water and light. 447 
Once it had been determined if the snails were infected and patent they were washed, to remove any 448 
cercariae, and preserved in 100% ethanol for molecular analysis. 449 
The MIX PCR was performed using gDNA (1 µl) extracted from six individual B. truncatus from 450 
each group that were preserved after 24 h, two non-patent snails from group 1 and 2, and one non-451 
patent snail from group 3 (11 weeks post exposure), and one patent (shedding) snail from group 2 452 
(11 weeks post exposure) (Table 3). The secondary SIX PCR was performed on selected Schistosoma 453 
positive samples, to amplify the 538bp S. haematobium specific amplicon for sequence analysis to 454 
confirm that the MIX PCR was not a false positive. 455 
Table 3. Groups of Bulinus truncatus (B.t.) experimentally challenged with either 1, 2 or ~7 S. 456 
haematobium (S.h.) miracidia and preserved 24 hours (h) post exposure or checked for patent S.h. 457 
infections and preserved 11 weeks (wks) post exposure. 458 
Infection 
Group 
No. of B.t. 
exposed 
No. of S.h. 
miracidia used  
No. of B.t. 
preserved at 24 h 
No. of B.t. checked for patency at 11 
wks and preserved (no. shedding 
+ve) 
1 45 1 22 221 (0) 
2 43 2 21 191 (2) 
3 45 ~7  23 211 (7) 
1 One B. truncatus died from each infection group during the 11 weeks post miracidia exposure. 459 
4.6. Specificity testing and validation on field samples 460 
As part of a longitudinal xenomonitoring project on Pemba in relation to urogenital 461 
schistosomiasis transmission [6], ‘wild caught’ B. globosus and B. nasutus field isolates were available 462 
for further validation of the MIX assay. Individual snails had been collected during malacological 463 
surveys, individually checked for patent trematode infections by cercarial shedding and then 464 
preserved in 100% ethanol for molecular analysis [6]. Cercariae from infected B. globosus were 465 
preserved on Whatman FTA cards and identified using molecular methods as S. haematobium or S. 466 
bovis from two and five snails, respectively [6]. In addition, individual B. globosus and B. nasutus (also 467 
collected from Pemba), which were shedding two other trematode species, Euclinostomum sp. and 468 
Echinostoma sp. respectively (unpublished data), were tested to investigate assay specificity. 469 
Additionally, 94 B. globosus snails from Wambaa (Pemba) collected during November 2018, that were 470 
not shedding any trematode cercariae were tested for infections by PCR.  471 
All samples that gave the 538 bp Schistosoma specific amplicon (Figure 7), were further subjected 472 
to the SIX PCR assay with the resulting amplicons purified and sequenced to confirm the species of 473 
the infection. S. haematobium and S. bovis species identity was confirmed by analysis of the four species 474 
SNP’s that exist in the ITS2 region [7] between S. haematobium and S. bovis (Table 3). 475 
4.7. Testing the Schistosoma cox1 rapid-diagnostic PCR (RD-PCR) for secondary species identification 476 
The patent B. globosus snails collected from Pemba shedding either S. haematobium (n = 2) or S. 477 
bovis (n = 5) (see [6]), as detailed above, were further tested using the published multiplex RD-PCR 478 
(see [27,33]) with an aim to provide a secondary species-specific screening method as described in 479 
Schols et al. (2019) [27]. This multiplex RD-PCR, capable of differentiating S. bovis and S. haematobium 480 
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by species-specific amplicon size (S. haematobium (543 bp) S. bovis (306 bp), was performed following 481 
the published protocol and cycling conditions described by Webster et al. (2010) [33]. Different 482 
amount of gDNA (1 µl, 2 µl and 3 µl) and PCR annealing temperatures (58ºC, 62ºC and 65ºC) were 483 
trialed to investigate sensitivity and specificity. Amplicons were purified and Sanger sequenced as 484 
described above, using the species-specific reverse primers to confirm species/amplicon 485 
identification. 486 
4.8. Ethical Statement 487 
Schistosoma haematobium experimental infections were conducted at the Biomedical Research 488 
Institute – Schistosomiasis Resource Centre (Rockville, MA, USA) animal facility maintained with 489 
AAALAC full accreditation (Site # 000779), operating under the National Institutes of Health’s Office 490 
of Laboratory Animal Welfare (OLAW) # A3080-01. S. haematobium parasite material was collected 491 
from male LVG Syrian golden hamsters following percutaneous exposure to cercariae. Hamster use 492 
was approved by the Institutional Animal Care and Use Committee (IACUC) of the Biomedical 493 
Research Institute for the Animal Use Protocol, #18-01. 494 
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